GPT and hepatocellular carcinoma: In this regard, the currently recommended timeline of antiviral treatments based on ALT levels may be a less effective means of preventing HCC, because such a strategy may cause a progressive decline in HBV DNA levels and a corresponding irreversible increase in HCC risk as a result of delayed treatment.